Get started

Buy-signal

U Unity Software short term price targetUnity Software`s game engine is used to create more than half of the world's mobile, console, and PC games. They recently bought Weta Digital, which created the special effects for The Lord of the Rings and Game of Thrones. I see a short term price target of $113 and a buy area if it will be the case when the interest rates will go higher at $90 - $95. Morgan Stanley has a price target of $185 for Unity Software, U. Looking forward to read your opinion about it.
NYSE:ULong
by TopgOptions
3
WAR WeStarter Cryptocurrency Launchpad at $1 Million Mk capWAR WeStarter is a cross-chain token initial swap platform which selects high-quality crypto projects that need fundraising before listing to major exchanges. It was launched in May 2021 at $2. Due to market conditions, the price is now $0.071 and the market cap is $1 million. The first financing was completed on April 15th, and the participated investment institutions include Continue Capital, SevenX Ventures, NGC Ventures, AU21 Capital, Spark Digital Capital, LD Capital, Power Law Capital, Kyros Ventures, DoraHacks Ventures, SkyVentures, DEFI TIMES CAPITAL and others. A similar incubator is SFUND Seedify, has a mk cap of $185Mil. So The upside potential is 185X from here just to reach SFUND`s market cap. Extremely low circulating supply, with few thousands usd, you ca substantially move the price. The RSI shows a massive bullish divergence. Increase in volume while decrease in price. Minimum upside potential is 10X in my opinion.
WLong
by TopgOptions
9
DWAC Truth Social app launching on Presidents Day, Feb. 21If you haven`t bough DWAC at my fist call, before it skyrocketed to $180: Then you should know that Truth Social's app profile page App Store seemed to point to the service launching on Feb. 21: Presidents Day. even though i don`t see a necessarily a correlation between the ride of DWAC and the fall of FB and TWTR, this was a mk cap comparison: I think Donald Trump will keep the stock`s momentum before the launch. Trump made statements suggested that people are leaving other social media platforms in anticipation for Truth Social. My price target for Presidents Day, Feb. 21 is the $113 resistance. Looking forward to read your opinion about it.
DLong
by TopgOptions
2
BBIG and the TYDE dividend! Buy opportunity????Cryptyde, a wholly owned subsidiary of Vinco Venture, BBIG, which is expected to trade, if approved by Nasdaq, under the symbol TYDE is a blockchain technology company focused on consumer adoption of smart contract technologies. For each 10 shares of BBIG you will get one share of TYDE. Secured convertible senior notes are expected to be sold to an institutional investor for $30 million and mature in 2025.The Notes convert into shares of Cryptyde common stock at $10.00 per share. So we can expect a $10 price per TYDE share. The price of BBIG shares is $2.83. So for 28.3usd you can expect a dividend stock worth $10. I think BBIG is a great buy opportunity right now. I see a $5.5 price target soon.
BLong
by TopgOptions
6
ARDS first Investor call of 2022. Phase 3 news ???Aridis Pharmaceuticals announced first Investor call of 2022 for today, after the closing bell. Exiting pipeline with 2 phase 3 drugs and their monoclonal antibody cocktail. AstraZeneca PLC (AZN) has a stake in this company. CEO has co-developed several drug which have been sold to Astra Zeneca, Megabits and MedImmune. Aridis Pharmaceuticals can be a potential buyout for AZN. Analyst Vernon Bernardino from H.C. Wainwright reiterated a buy rating and $19 price target on ARDS: "the cocktail binds to the S2 spike protein subunit, which mediates viral cell membrane fusion in SARS-CoV-2 variants and also binds to the omicron variant with no loss in affinity compared to the original Wuhan strain." Aridis Pharmaceuticals Inc 's monoclonal Covid-19 Antibody Cocktail is potentially First-in-Class treatment! Cantor Fitzgerald also said last week that Aridis' pipeline is "underappreciated." ARDS Pan-Coronavirus Monoclonal Antibody Cocktail Retains Effectiveness Against the Omicron variant, other COVID-19 Variants, SARS, MERS , and the Common Cold Human Coronaviruses. It provides relevant drug levels for up to 1 year from prophylactic or therapeutic treatment. Market Cap of only 22.48Mil 52 Week Range 1.13 - 8.4
ALong
by TopgOptions
2